Abstract
We report a 54 year old female whose successful treatment of cerebral lupus with rituximab was complicated by the development of streptococcus intermedius, on valves damaged by Libman-Sacks endocarditis more than 20 years previously.
MeSH terms
-
Anti-Bacterial Agents / therapeutic use
-
Antibiotic Prophylaxis
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Murine-Derived
-
Antirheumatic Agents / adverse effects
-
Antirheumatic Agents / therapeutic use*
-
Cefotaxime / therapeutic use
-
Endocarditis, Bacterial / drug therapy*
-
Female
-
Humans
-
Lupus Erythematosus, Systemic / complications*
-
Lupus Erythematosus, Systemic / drug therapy*
-
Lupus Erythematosus, Systemic / physiopathology
-
Middle Aged
-
Penicillin G / therapeutic use
-
Rituximab
-
Streptococcal Infections / complications*
-
Streptococcal Infections / drug therapy
-
Streptococcus intermedius / isolation & purification
Substances
-
Anti-Bacterial Agents
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Murine-Derived
-
Antirheumatic Agents
-
Rituximab
-
Cefotaxime
-
Penicillin G